bruce cree, md, phd, mas: inebilizumab for nmosd treatment
Published 4 years ago • 460 plays • Length 4:41Download video MP4
Download video MP3
Similar videos
-
3:10
bruce cree, md, phd, mas: inebilizumab in neuromyelitis optica spectrum disorder
-
4:26
bruce cree, md, phd, mas: the nmosd landscape after the inebilizumab approval
-
4:15
bruce cree, md, phd, mas: the future landscape in nmosd
-
3:46
bruce cree, md, phd, mas: insights from the n-momentum study of inebilizumab
-
4:04
day-to-day care of nmosd, advances and challenges: bruce cree, md, phd, mas, faan
-
3:12
analyzing long term, end of study results for inebilizumab treatment in nmosd
-
0:56
bruce cree – ectrims 2022
-
6:18
soliris® (eculizumab) mechanism of action for neuromyelitis optica spectrum disorder (nmosd)
-
5:42
s
-
4:16
story of recovery: demetris brisby's neuromyelitis optica | brooks rehabilitation
-
4:04
long term benefits of inebilizumab revealed in n momentum analysis
-
5:43
inebilizumab treatment in newly diagnosed nmosd patients
-
2:44
updates on n-momentum: inebilizumab versus placebo in patients with nmosd
-
2:00
bruce cree, md, phd: long-term data collection in ms studies
-
3:35
the payer dilemma with accessing effective therapies for nmosd
-
4:41
challenges and potential of btk inhibitors in ms treatment
-
3:22
aan 2021 highlights: two-year efficacy and safety data with inebilizumab to treat nmosd
-
5:22
tips for diagnosing neuromyelitis optica spectrum disorder
-
57:39
advances in s1pr modulation: progress in understanding brain atrophy and cognition measures in ms
-
2:16
bruce cree, md, phd: brain volume loss and disability progression in ms
-
1:57
which clinician usually diagnoses neuromyelitis optica spectrum disorder?
-
4:38
inebilizumab as a potential therapy for autoimmune encephalitis